▼ SELL
10b5-1 Plan
$ Value
$266K
Shares
12,060
Price
$22
Filed
Nov 13
Insider
Name
Cross Shawn
Title
Chief Financial Officer
CIK
0001734779
Roles
Officer
Transaction Details
Transaction Date
2025-11-10
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
56,250
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Filing Info
Cross Shawn's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-22 | PCRX | M | $25K |
| 2026-04-22 | PCRX | ▼ | $38K |
| 2026-04-22 | PCRX | M | $0 |
| 2026-04-21 | PCRX | M | $47K |
| 2026-04-21 | PCRX | ▼ | $71K |
| 2026-04-21 | PCRX | M | $0 |
| 2026-04-20 | PCRX | M | $127K |
| 2026-04-20 | PCRX | ▼ | $194K |
| 2026-04-20 | PCRX | M | $0 |
| 2026-02-11 | PCRX | A | $0 |
Other Insiders at PCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILLIAMS KRISTEN
Chief Administrative Officer
|
— | $270K | 2026-02-11 |
|
RIKER LAUREN
Senior Vice President, Finance
|
— | $83K | 2026-02-11 |
|
Cross Shawn
Chief Financial Officer
|
— | $303K | 2026-04-22 |
| Hirawat Samit | — | — | 2026-01-27 |
|
Lee Frank D.
Chief Executive Officer
|
— | — | 2026-02-11 |
|
SLONIN JONATHAN
Chief Medical Officer
|
— | — | 2026-02-11 |
|
Teehan Brendan
Chief Commercial Officer
|
— | — | 2026-02-11 |